PER 4.65% 9.0¢ percheron therapeutics limited

Ann: US FDA Feedback on Type C Meeting for ATL1102 in the US, page-176

  1. 2,197 Posts.
    lightbulb Created with Sketch. 160
    of course I did, otherwise I won’t invest! This is a low risk stock backed up by a promising product. However it is not risk free as we still have a trial ahead for DMD, that is NOT yet sorted, and cheerleaders already talk about dementia, Alzheimer’s or Parkinson’s? where are the indications for these conditions?




 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
9.0¢
Change
0.004(4.65%)
Mkt cap ! $81.13M
Open High Low Value Volume
8.6¢ 9.1¢ 8.5¢ $181.6K 2.049M

Buyers (Bids)

No. Vol. Price($)
1 10344 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
9.0¢ 64275 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.